Zoetis EBITDA 2012-2025 | ZTS

Zoetis annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Zoetis EBITDA for the quarter ending September 30, 2025 was $1.069B, a 1.62% increase year-over-year.
Zoetis EBITDA for the twelve months ending September 30, 2025 was $4.036B, a 6.66% increase year-over-year.
Zoetis 2024 annual EBITDA was $3.855B, a 5.16% increase from 2023.
Zoetis 2023 annual EBITDA was $3.666B, a 9.69% increase from 2022.
Zoetis 2022 annual EBITDA was $3.342B, a 5.76% increase from 2021.

Zoetis Annual EBITDA (Millions of US $)
2024	$3,855
2023	$3,666
2022	$3,342
2021	$3,160
2020	$2,668
2019	$2,436
2018	$2,204
2017	$1,942
2016	$1,634
2015	$868
2014	$1,141
2013	$1,012
2012	$941
2011	$635

Zoetis Quarterly EBITDA (Millions of US $)
2025-09-30	$1,069
2025-06-30	$1,078
2025-03-31	$983
2024-12-31	$906
2024-09-30	$1,052
2024-06-30	$966
2024-03-31	$931
2023-12-31	$835
2023-09-30	$900
2023-06-30	$1,051
2023-03-31	$880
2022-12-31	$773
2022-09-30	$835
2022-06-30	$840
2022-03-31	$894
2021-12-31	$677
2021-09-30	$825
2021-06-30	$805
2021-03-31	$853
2020-12-31	$587
2020-09-30	$770
2020-06-30	$651
2020-03-31	$660
2019-12-31	$602
2019-09-30	$691
2019-06-30	$608
2019-03-31	$535
2018-12-31	$578
2018-09-30	$556
2018-06-30	$546
2018-03-31	$524
2017-12-31	$543
2017-09-30	$514
2017-06-30	$445
2017-03-31	$440
2016-12-31	$335
2016-09-30	$434
2016-06-30	$433
2016-03-31	$432
2015-12-31	$162
2015-09-30	$348
2015-06-30	$52
2015-03-31	$306
2014-12-31	$238
2014-09-30	$317
2014-06-30	$280
2014-03-31	$306
2013-12-31	$214
2013-09-30	$263
2013-06-30	$270
2013-03-31	$265
2012-12-31	$134
2012-09-30	$274
2012-06-30	$314
2012-03-31	$227
2011-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$55.228B	$9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.220B	33.89
Takeda Pharmaceutical (TAK)	Japan	$51.739B	10.56
Daiichi Sankyo, - (DSNKY)	Japan	$43.684B	21.75
BeOne Medicines - (ONC)	Switzerland	$36.626B	194.18
Sandoz Group AG (SDZNY)	Switzerland	$33.097B	0.00
United Therapeutics (UTHR)	United States	$20.770B	18.28
Merck (MKKGY)	Germany	$19.845B	12.23
Shionogi (SGIOY)	Japan	$15.823B	14.53
Neurocrine Biosciences (NBIX)	United States	$13.227B	31.74
Ionis Pharmaceuticals (IONS)	United States	$13.227B	0.00
Summit Therapeutics (SMMT)	United States	$13.140B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.595B	0.00
Orion OYJ (ORINY)	Finland	$11.045B	31.56
Eisai (ESAIY)		$8.889B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Grifols, S.A (GRFS)	Spain	$6.284B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.278B	35.14
Crinetics Pharmaceuticals (CRNX)	United States	$5.252B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.321B	17.63
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.080B	19.37
Corcept Therapeutics (CORT)	United States	$3.930B	42.46
NewAmsterdam Pharma (NAMS)	Netherlands	$3.707B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.960B	0.00
Hypermarcas (HYPMY)	Brazil	$2.882B	19.78
Catalyst Pharmaceuticals (CPRX)	United States	$2.854B	9.11
Dyne Therapeutics (DYN)	United States	$2.494B	0.00
Ocular Therapeutix (OCUL)	United States	$2.277B	0.00
Soleno Therapeutics (SLNO)	United States	$2.231B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.015B	23.88
Guardian Pharmacy Services (GRDN)	United States	$1.995B	38.43
Ardelyx (ARDX)	United States	$1.788B	0.00
Harrow (HROW)	United States	$1.772B	108.73
Collegium Pharmaceutical (COLL)	United States	$1.522B	7.54
BioCryst Pharmaceuticals (BCRX)	United States	$1.494B	88.62
Oruka Therapeutics (ORKA)	United States	$1.486B	0.00
Enliven Therapeutics (ELVN)	United States	$1.485B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.361B	0.00
Relay Therapeutics (RLAY)	United States	$1.352B	0.00
Evotec AG (EVO)	Germany	$1.335B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.306B	0.00
Savara (SVRA)	United States	$1.174B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.125B	0.00
Cronos Group (CRON)	Canada	$1.025B	0.00
Xencor (XNCR)	United States	$1.012B	0.00
Theravance Biopharma (TBPH)	United States	$0.996B	41.81
Esperion Therapeutics (ESPR)	United States	$0.849B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.828B	0.00
Nektar Therapeutics (NKTR)	United States	$0.789B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.727B	17.19
Rigel Pharmaceuticals (RIGL)	United States	$0.725B	6.48
ProKidney (PROK)	United States	$0.701B	0.00
Bioventus (BVS)	United States	$0.641B	13.14
Lexeo Therapeutics (LXEO)	United States	$0.593B	0.00
Organogenesis (ORGO)	United States	$0.537B	0.00
Lyell Immunopharma (LYEL)	United States	$0.505B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.497B	0.00
Siga Technologies (SIGA)	United States	$0.472B	6.46
Zevra Therapeutics (ZVRA)	United States	$0.472B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.429B	0.00
Aquestive Therapeutics (AQST)	United States	$0.428B	0.00
Altimmune (ALT)	United States	$0.423B	0.00
Nature's Sunshine Products (NATR)	United States	$0.390B	23.25
USANA Health Sciences (USNA)	United States	$0.377B	10.51
Akebia Therapeutics (AKBA)	United States	$0.372B	0.00
Profound Medical (PROF)	Canada	$0.314B	0.00
Avalo Therapeutics (AVTX)	United States	$0.309B	0.00
Relmada Therapeutics (RLMD)	United States	$0.301B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.301B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.288B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.279B	0.00
OmniAb (OABI)	United States	$0.275B	0.00
Fractyl Health (GUTS)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Protara Therapeutics (TARA)	United States	$0.271B	0.00
Larimar Therapeutics (LRMR)	United States	$0.269B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.248B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.226B	0.00
Journey Medical (DERM)	United States	$0.210B	0.00
Galectin Therapeutics (GALT)	United States	$0.204B	0.00
VAXART, INC (VXRT)	United States	$0.192B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.192B	0.00
MediWound (MDWD)	Israel	$0.191B	0.00
Minerva Neurosciences (NERV)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.178B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
AleAnna (ANNA)	United States	$0.155B	0.00
Surrozen (SRZN)	United States	$0.154B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.150B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.140B	0.00
Prelude Therapeutics (PRLD)	United States	$0.138B	0.00
Context Therapeutics (CNTX)	United States	$0.137B	0.00
Incannex Healthcare (IXHL)	Australia	$0.135B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.129B	0.00
Pyxis Oncology (PYXS)	United States	$0.128B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.128B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.126B	0.00
Avita Medical (RCEL)	United States	$0.104B	0.00
Cassava Sciences (SAVA)	United States	$0.102B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.096B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Champions Oncology (CSBR)	United States	$0.093B	39.53
Korro Bio (KRRO)	United States	$0.084B	0.00
Gain Therapeutics (GANX)	United States	$0.082B	0.00
PolyPid (PYPD)	Israel	$0.074B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.071B	59.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
Plus Therapeutics (PSTV)	United States	$0.068B	0.00
Arch Biopartners (ACHFF)	Canada	$0.067B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.066B	0.00
Metagenomi (MGX)	United States	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Assertio Holdings (ASRT)	United States	$0.060B	0.00
Lite Strategy (LITS)	United States	$0.053B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.051B	0.00
Nutriband (NTRB)	United States	$0.051B	0.00
ElectroCore (ECOR)	United States	$0.051B	0.00
Lipocine (LPCN)	United States	$0.050B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.037B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.031B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Klotho Neurosciences (KLTO)	United States	$0.025B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.017B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.014B	0.00
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Traws Pharma (TRAW)	United States	$0.010B	0.01
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.007B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00